Top Markets
#1 Derive Derive +34.71%
#2 Cross Cross +19.12%
#3 Geodnet Geodnet +11.72%
#4 Palladium Network Palladium Network +11.56%
#5 Gama Token Gama Token +9.18%
#6 The Bitcoin Bull The Bitcoin Bull +8.57%
#7 Biconomy Biconomy +8.06%
#8 Quantum Resistant Ledger Quantum Resistant Ledger +7.74%
#9 Steakhouse ETH Morpho Vault Steakhouse ETH Morpho Vault +7.00%
#10 Humanity Humanity +6.54%
Coin of the day
Derive Derive
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Coala-Life Group AB (publ) Coala-Life Group AB (publ)

Coala-Life Group AB (publ)

COALA
Clasificación en acciones #36346
Coala-Life Group AB (publ) is a medical technology firm that specializes in the... Coala-Life Group AB (publ) is a medical technology firm that specializes in the development, manufacturing, and sale of advanced cardiac diagnostics and mobile health products. The company's flagship offering is the Coala Heart Monitor, a comprehensive medical device and associated service designed for digital remote surveillance, analytical assessment, and personal self-screening of heart conditions. Coala-Life Group AB (publ) was founded in 2004 and maintains its headquarters in Uppsala, Sweden.
Precio por acción
$0.0019323
Última sincronización: 2024-07-12
Capitalización bursátil
$2.78M
Cambio (1 día)
16.91%
Cambio (1 año)
0.00%
País
SE
Comercio Coala-Life Group AB (publ) (COALA)

Categoría

Healthcare
Ganancias de Coala-Life Group AB (publ) (COALA)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Coala-Life Group AB (publ), gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Coala-Life Group AB (publ) desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
$7.51B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
$5.15B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
$5.56B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
$3.86B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
$1.42B -
US